Dolorol
Dolorol, licence 80112012: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Royal Academy of Nutrition Science
- NPN or DIN-HM
- 80112012
- Status
- Active licence
- Licence date
- 11 August 2021
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Corydalis yanhusuo Source : Tubercule Extract : Matériel brut sec Extraction ratio : 20.0:1.0 Dry plant equivalent : 2500.0 mg | 125.0 mg | Not calculated |
| Curcuma kwangsiensis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 30.0:1.0 Dry plant equivalent : 2250.0 mg | 75.0 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 100.0 mg | Not calculated |
| Rosa roxburghii Source : Fruit Extract : Matériel brut sec Extraction ratio : 15.0:1.0 Dry plant equivalent : 1500.0 mg | 100.0 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 60.0 mg | 240,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. Corydalis Rhizome/ Corydalis yanhusuo is used in Traditionally Chinese Medicine to invigorate blood, promote the movement of qi, and relieve pain caused by qi and blood stagnation in the chest, abdomen, hypochondrium and limbs, such as pain associated with menstruation, and epigastric/abdominal pain. Curcuma Rhizome/ Curcuma kwangsiensis is used in Traditional Chinese Medicine to promote the movement of qi, invigorate the blood, and help relieve abdominal pain due to food stagnation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80112012
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.